IP Library Granted Patent US 8,353,837
Granted Patent B2
US 8,353,837 · App. 12/700,692 · Granted Jan 15, 2013

Modulation and analysis of cerebral perfusion in epilepsy and other neurological disorders

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,353,837
App. No.
12/700,692
Granted
Jan 15, 2013
Kind
B2
Abstract

A system including an implantable neurostimulator device capable of modulating cerebral blood flow to treat epilepsy and other neurological disorders. In one embodiment, the system is capable of modulating cerebral blood flow (also referred to as cerebral perfusion) in response to measurements and other observed conditions. Perfusion may be increased or decreased by systems and methods according to the invention as clinically required.

Claims (20)

1. A method for responding to a neurological disorder in a human patient comprising:

obtaining a perfusion measurement with an implantable device;

identifying a change in the cerebral perfusion measurement;

in response to the change, performing an action; and

identifying a structure in a hemisphere demonstrating increased blood flow, and wherein performing the action comprises stimulating a neural structure in a hemisphere contralateral to the hemisphere demonstrating a structure with the increased blood flow.

2. A method for responding to a neurological disorder in a human patient comprising:

obtaining a perfusion measurement with an implantable device;

identifying a change in the cerebral perfusion measurement; and

in response to the change, performing an action, wherein obtaining the cerebral perfusion measurement comprises:

observing a first signal from a first implanted sensor;

observing a second signal from a second implanted sensor; and

calculating the perfusion as a composite of the first signal and the second signal, wherein the first implanted sensor is positioned to measure the first signal from an artery feeding a location and the second implanted sensor is positioned to measure the second signal from a vein leaving the location.

3. A method for responding to a neurological disorder in a human patient comprising:

obtaining a perfusion measurement with an implantable device;

identifying a change in the cerebral perfusion measurement; and

in response to the change, performing an action, wherein obtaining the cerebral perfusion measurement comprises:

observing a first signal from a first implanted sensor;

observing a second signal from a second implanted sensor; and

calculating the perfusion as a composite of the first signal and the second signal, wherein performing the action comprises:

delivering a therapy to modulate the cerebral perfusion measurement, wherein delivering the therapy causes the first signal to more closely resemble the second signal.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jun 4, 2025
From: CRG SERVICING LLC AS SUCCESSOR TO CAPITAL ROYALTY PARTNERS II L.P., CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P., AND PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: NEUROPACE INC.
Reel/Frame 071495/0800 →
SECURITY INTEREST Recorded Sep 25, 2020
From: NEUROPACE, INC.
To: CRG SERVICING LLC
Reel/Frame 053885/0932 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Nov 20, 2014
From: NEUROPACE, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 034410/0767 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2010
From: PLESS, BENJAMIN D; JOHN, MICHAEL SASHA; WINGEIER, BRETT
To: NEUROPACE, INC.
Reel/Frame 023986/0157 →